Nuclear Medicine

In Other News

• Benefits of PET or PET/CT Imaging Unproven in Recurrent Bowel Cancer

• Radiopharmaceuticals Can More Effectively Manage Treatment and Predict Survival for Patients with Gliomas

• Combining MRI and PET with CSF Analysis Provides a Better Prediction of Alzheimer’s Disease

• Molecular Breast Imaging Improves Early Detection in High-Risk Women

• Innovative Chair Allows Patients to Sit During Cancer Treatments

• Radiology Societies Collaborate to Promote Use of Lower Radiopharmaceutical Doses in Nuclear Imaging Scans

• Kenyan Hospital to Treat Cancer with Advanced Radiotherapy

• Ultrasound Workstation Protects Technicians from Endocavity Probe-Processing Vapors

• Alzheimer’s Drug Suppresses Cognitive Decline in Brain Tumor Patients Who Undergo Whole Brain Radiotherapy

• Neuroimaging Cannot Detect Autism by Itself

• Low-Dose Molecular Breast Imaging Evaluated in the Detection of Breast Cancer

• Brachytherapy Results in More Complications in Older Breast Cancer Patients

• Nuclear Medicine Software Developed for Greater Productivity and Workflow Improvements

• Proton Therapy Room Designed to Offer Comfort, Relaxation to Patient

• PET Radiopharmaceutical Receives European Endorsement for Imaging of β-Amyloid Density

• New Radiation Treatment Significantly Increases Survival Rate

• Body GPS, Real-Time Tracking System Used for Prostate Radiotherapy

• PET Offers Prediction of Early Response to Head and Neck Cancer Treatment

• Leading Cancer Center Uses High-Intensity Radiotherapy to Deliver Precise Brain Radiosurgery

• SPECT/CT Technique Provides Improved Detection of Lymph Node Metastasis in Patients with Melanoma

• New PET Imaging Agent Has Potential for Diagnosing Alzheimer’s

• PET Imaging Agent for Detection of Tau Pathologies Shows Promise for Alzheimer’s Patients

• Pretreatment PET Imaging of Lymph Nodes Predicts Recurrence in Breast Cancer Patients